Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd. Common Stock (MDCX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · MDCX · as of Sep 30, 2025
Ownership Breakdown
20
Institutional Holders
▼ 1 vs Q2
$4.91M
Total Inst. Value
▼ $1.69M vs Q2
22.04M
Shares Outstanding
freeFloat 19.78%
2.12M
13F Shares Held
▼ 86,585 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
MDCX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
INTERCHANGE CAPITAL PARTNERS, LLC pharmaceutical preparations | 1.59M | 8.52% | 8.52% | $3.67B | Nov 12, 2025 | — held |
YORKVILLE ADVISORS GLOBAL, LP pharmaceutical preparations | 230.0K | 1.23% | 1.23% | $532.45M | Nov 18, 2025 | ▲ 124.2K |
PRIVATE ADVISOR GROUP, LLC pharmaceutical preparations | 151.5K | 81.31% | 81.31% | $350.72M | Nov 13, 2025 | ▲ 5.5K |
BRYN MAWR TRUST CO pharmaceutical preparations | 25.6K | 13.75% | 13.75% | $59.31M | Nov 20, 2025 | NEW |
BRAVE ASSET MANAGEMENT INC pharmaceutical preparations | 20.0K | 10.73% | 10.73% | $46.30M | Oct 21, 2025 | NEW |
LPL FINANCIAL LLC pharmaceutical preparations | 18.8K | 10.06% | 10.06% | $43.41M | Nov 12, 2025 | NEW |
MAY HILL CAPITAL, LLC pharmaceutical preparations | 17.8K | 9.56% | 9.56% | $41.23M | Nov 7, 2025 | ▼ 17.8K |
BLACKROCK, INC. pharmaceutical preparations | 16.2K | 8.70% | 8.70% | $37.54M | Nov 12, 2025 | ▲ 452 |
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 14.0K | 7.51% | 7.51% | $31.43M | Nov 14, 2025 | — held |
pharmaceutical preparations | 11.5K | 6.20% | 6.20% | $26.72M | Oct 20, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
3
Increased
+130.1K shares7
New Positions
first time holders5
Decreased
−49.7K shares8
Sold Out
fully exitedNet shares change (top 50)
+80.4K
+130.1K / −49.7K
Net new holders
-3
7 new / 8 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
MDCX insider trading · insider activity
Source: SEC Form 4
13
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Smith Andrew Alasdair Chief Operating Officer | Jun 3, 2026 | Award | 200,000 | $0.36 | $72.0K | 200.0K | Form 4 ↗ |
Rodgers Cathy McMorris director | Jun 3, 2026 | Award | 50,000 | $0.36 | $18.0K | 50.0K | Form 4 ↗ |
Raju Ajay director | Jun 3, 2026 | Award | 50,000 | $0.36 | $18.0K | 50.0K | Form 4 ↗ |
Mehmud Faisal Chief Medical Officer | Jun 3, 2026 | Award | 250,000 | $0.36 | $90.0K | 250.0K | Form 4 ↗ |
May Sara R. director | Jun 3, 2026 | Award | 50,000 | $0.36 | $18.0K | 50.0K | Form 4 ↗ |
MAHAFFY PATRICK J director | Jun 3, 2026 | Award | 50,000 | $0.36 | $18.0K | 50.0K | Form 4 ↗ |
Kaiser Larry director | Jun 3, 2026 | Award | 50,000 | $0.36 | $18.0K | 50.0K | Form 4 ↗ |
FISHMAN BARRY director | Jun 3, 2026 | Award | 50,000 | $0.36 | $18.0K | 50.0K | Form 4 ↗ |
Ciaruffoli Robert J. director | Jun 3, 2026 | Award | 50,000 | $0.36 | $18.0K | 50.0K | Form 4 ↗ |
Brennan Edward J. Chief Scientific Officer | Jun 3, 2026 | Award | 25,000 | $0.36 | $9.0K | 25.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Medicus Pharma Ltd. Common Stock (MDCX) is primarily owned by institutional investors, who hold approximately 9.6% of total shares outstanding. Company insiders own approximately 80.22%, while retail and public investors account for the remaining 10.16%.
The largest institutional shareholder of Medicus Pharma Ltd. Common Stock is INTERCHANGE CAPITAL PARTNERS, LLC, holding approximately 1.59 million shares — equal to 8.52% of outstanding shares — as of September 30, 2025.
A total of 20 institutional investors currently hold MDCX stock, with a combined institutional value of approximately $4,905,211 as of the most recent 13F filing period.
Frequently asked questions
MDCX ownershipMedicus Pharma Ltd. Common Stock (MDCX) is primarily owned by institutional investors, who hold approximately 9.6% of shares. The largest shareholder is INTERCHANGE CAPITAL PARTNERS, LLC with a 8.52% stake. Company insiders hold 80.22%. Data sourced from SEC Form 13F as of September 30, 2025.